Literature DB >> 6731617

Hyperprolactinemia, distress, and hostility.

R Kellner, M T Buckman, G A Fava, D Pathak.   

Abstract

The scores of 14 women with hyperprolactinemia on the Symptom Rating Test and the Symptom Questionnaire were compared with those of nonpsychotic women attending a psychiatric clinic, women attending a family practice clinic, and female nonpatient employees. The scores of the hyperprolactinemic women were similar to those of the psychiatric patients. Hyperprolactinemic patients were significantly more hostile, depressed, and anxious and had more feelings of inadequacy than family practice patients and nonpatient employees. The authors recommend measuring the serum prolactin levels of women with depression, hostility, anxiety, and symptoms or signs suggestive of hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6731617     DOI: 10.1176/ajp.141.6.759

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  6 in total

1.  Postmortem prolactin as a marker of antemortem stress.

Authors:  T J Jones; M J Hallworth
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

Review 2.  Prolactin, psychological stress and environment in humans: adaptation and maladaptation.

Authors:  Luis Gonçalves Sobrinho
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

3.  Voice pitch alters mate-choice-relevant perception in hunter-gatherers.

Authors:  Coren L Apicella; David R Feinberg
Journal:  Proc Biol Sci       Date:  2009-03-22       Impact factor: 5.349

4.  Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study.

Authors:  Roberto Brugnoli; Diego Novick; Josep Maria Haro; Andrea Rossi; Marco Bortolomasi; Sonia Frediani; Giuseppe Borgherini
Journal:  BMC Psychiatry       Date:  2012-07-19       Impact factor: 3.630

5.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

6.  Prolactin and aggression in women with fertility problems.

Authors:  J A Barry; E Moran; H S Parekh; T Morewood; M Thomas; P J Hardiman
Journal:  J Obstet Gynaecol       Date:  2014-10       Impact factor: 1.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.